Titlebook: Chronic Myeloid Leukemia; Rüdiger Hehlmann Book 2021Latest edition The Editor(s) (if applicable) and The Author(s), under exclusive licens

思鄉(xiāng)病

Formidable

輕彈

牛馬之尿

出汗

Prognostic Scores for Patients with Chronic Myeloid Leukemia under Particular Consideration of Disereating other causes of death as competing risks are highlighted. In the presence of competing risks, the application of both the cause-specific hazard model and the subdistribution hazard model is recommended when investigating the influence of prognostic factors on the event of interest. A detaile

Abnormal

A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloiee remission has become a goal of CML treatment, although, so far, it can be reached by a minority of patients. In this chapter we discuss these advances and other still open issues in CML management, analyzing some key points of the ELN 2020 recommendations.

顯微鏡

Malaise

CML End Phase and Blast Crisis: Implications and Management, of TKI should be directed by the mutation profile of the patient. Also, a better pathophysiologic understanding of BC is addressed. Current treatment options are combined in a concluding strategy for the management of CML end phase and BC.

調(diào)味品

chance

Managing Pregnancy in Chronic Myeloid Leukaemia,lity in either male or female patients. However, and dependent on individual circumstances, it may be useful to discuss the options for fertility preservation including semen cryopreservation, ovarian or oocyte retrieval and storage and embryo cryopreservation. The TKI are teratogenic and should not